Table 1 Demographic and clinical characteristics
Characteristics | African American (AA) | Caucasian (CA) |
|---|---|---|
Age at Surgery (Yrs.) | ||
Median (Range) | 66 (35, 88) | 68 (40, 97) |
IQR (1st quartile, 3rd quartile) | 21 (55–76) | 20 (57–77) |
Gender | ||
Female (n = 118) | 63 (51.6 %) | 55 (45.1 %) |
Male (n = 126) | 59 (48.4 %) | 67 (54.9 %) |
Surgery Year | ||
<2000 | 38 (31.2 %) | 38 (31.2 %) |
≥2000 and <2010 | 49 (40.2 %) | 60 (49.2 %) |
≥2010 | 35 (28.7 %) | 24 (19.7 %) |
Number of Nodes Examined | ||
Median (Range) | 15 (1, 52) | 17 (1, 50) |
IQR (1st quartile, 3rd quartile) | 14 (9, 23) | 15 (10, 25) |
Tumor Location | ||
Ascending (Ascending, Cecum, Hepatic flexure, Transverse) | 71 (58.2 %) | 72 (59.0 %) |
Descending (Descending, Sigmoid, Splenic flexure) | 45 (36.9 %) | 46 (37.7 %) |
Colon NOS | 6 (4.9 %) | 4 (3.3 %) |
T Stage | ||
T3 | 107 (87.7 %) | 109 (89.3 %) |
T4 | 15 (12.3 %) | 13 (10.7 %) |
MMR Status | ||
Deficient | 11 (9.0 %) | 21 (17.2 %) |
Proficient | 111 (91.0 %) | 101 (82.8 %) |
Lympho-vascular Invasion | ||
Yes | 7 (5.7 %) | 6 (4.9 %) |
No | 95 (77.9 %) | 97 (79.5 %) |
Not Reported | 20 (16.4 %) | 19 (15.6 %) |